During the past decade, Integrated University Hospital Santa Maria della Misericordia of Udine conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Integrated University Hospital Santa Maria della Misericordia of Udine" are "Crohn Disease" (3 trials), "Candidemia" (1 trials), "Fungal Infection" (1 trials), "Invasive Candidiases" (1 trials) and "Mycoses" (1 trials). Many other conditions were trialed in "Integrated University Hospital Santa Maria della Misericordia of Udine" in a lesser frequency.

Most popular intervention types in "Integrated University Hospital Santa Maria della Misericordia of Udine" are "Drug" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ozanimod" (3 trials), "Placebo" (2 trials), "Caspofungin" (1 trials), "Fluconazole" (1 trials) and "Rezafungin for Injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Integrated University Hospital Santa Maria della Misericordia of Udine" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Integrated University Hospital Santa Maria della Misericordia of Udine". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Integrated University Hospital Santa Maria della Misericordia of Udine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Integrated University Hospital Santa Maria della Misericordia of Udine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".